Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis

Circulation

Volumn 103, Issue 18, 2001, Pages 2289-2295

  Heldman, Alan W ^a,c   Cheng, Linda ^a   Jenkins, G Mark ^a   Heller, Phillip F ^a   Kim, Dong Woon ^a   Ware Jr , Melvin ^a   Nater, Cynthia ^a   Hruban, Ralph H ^a   Rezai, Banafsheh ^a   Abella, Benjamin S ^a   Bunge, Katherine E ^a   Kinsella, James L ^a   Sollott, Steven J ^a   Lakatta, Edward G ^a   Brinker, Jeffrey A ^a   Hunter, William L ^b   Froehlich, Jeffrey P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Angiotech Pharmaceuticals Inc   (Canada)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Angioplasty; Paclitaxel; Restenosis; Stents

Indexed keywords

PACLITAXEL;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DYSPLASIA; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CORONARY STENT; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; IMPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; THROMBOSIS;

EID: 14344268774     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.18.2289     Document Type: Article

References (21)

1. Popma JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation. 1991;84:1426-1436.
2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J J Med. 1994;331:489-495.
3. Edelman ER, Rogers C. Hoop dreams: stents without restenosis. Circulation. 1996;94:1199-1202.
4. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2000;101:360-365.
5. 32P radioactive β-emitting stent implantation in patients with coronary artery disease: the Milan dose-response study. Circulation. 2000;101:18-26.
6. Costa MA, Sabaté M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation. 1999;100:789-792.
7. Sollott SJ, Cheng L, Pauly RR, et al. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 1995;95:1869-1876.
8. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645.
9. Wani MC, Taylor HL, Wall ME, et al. Plant antitumor agents, VI: the isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971;93:2325-2327.
10. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med. 1995; 332:1004-1014.
11. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA. 1980;77:1561-1565.
12. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690-1697.
13. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
14. Brieger D, Topol E. Local drug delivery systems and prevention of restenosis. Cardiovasc Res. 1997;35:405-413.
15. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
16. Herdeg C, Oberhoff M, Baumbach A, et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol. 2000;35:1969-1976.
17. Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neoimimal hyperplasia in rabbits. Circulation. 1995;92:1570-1575.
18. Laird JR, Carter AJ, Kufs WM, et al. Inhibition of neointimal proliferation with low-dose radiation from a β-particle-emitting stent. Circulation. 1996;93:529-536.
19. 32P β-particle emitting stents in a canine model. Circulation. 1999;100:2366-2372.
20. Baumbach A, Herdeg C, Kluge M, et al. Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall. Cathet Cardiovasc Intervent. 1999;47:102-106.
21. Komowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224-230.